Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oncobiologics Inc. completes IPO

Oncobiologics Inc. (NASDAQ:ONS), Cranbury, N.J.
Business: Antibodies, Autoimmune, Cancer

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE